Global Neurovascular Thrombectomy Devices Market to 2026 – Insights, Competitive Landscape and Market Forecast – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Neurovascular Thrombectomy Devices Market Insights, Competitive Landscape and Market Forecast – 2026” report has been added to ResearchAndMarkets.com’s offering.

This report delivers an in-depth understanding of Neurovascular Thrombectomy Devices and the historical and forecasted Neurovascular Thrombectomy Devices market trends in the US, EU5 (Germany, France, Spain, Italy, and the United Kingdom) and Japan.

The Neurovascular Thrombectomy Devices market report provides an overview of Neurovascular Thrombectomy Devices, applications of Neurovascular Thrombectomy Devices as well as its PEST Analysis. Additionally, the report provides insight on the Neurovascular Thrombectomy Devices market share of the individual Neurovascular Thrombectomy Devices, current and forecasted Neurovascular Thrombectomy Devices market size from 2018 to 2026 segmented by seven major markets. The report also covers the market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses underlying potential of the market.

Market Drivers

• Increase in the Ageing Population
• Increase in Incidence and Prevalence of Neurovascular Diseases
• Technological Advancements in Minimally Invasive Products
• Favorable Reimbursement Policies
• Acquisitions and Partnerships as a Part of the Growth Strategy

Market Barriers

• Complications with the Implantations of Neurovascular Thrombectomy Devices
• Lack of Skilled and Trained Professionals
• Availability of Alternative Products
• Adverse Events and Product Recalls

KOL- Views

To keep up with the market trends, we take KOLs and SME’s opinion working in Neurovascular Thrombectomy Devices domain through primary research to fill the data gaps and validate our secondary research. Their opinion helps to understand and validate current and emerging therapies treatment patterns or Neurovascular Thrombectomy Devices market trend. This will support the clients in making informed business decisions by identifying the overall scenario of the market and the unmet needs.

Scope of the Report

• The report covers the descriptive overview of Neurovascular Thrombectomy Devices, explaining its applications, advantages, and limitations, etc.
• Additionally, an all-inclusive account of the currently available Neurovascular Thrombectomy Devices is provided, which will have an impact on the future market of Neurovascular Thrombectomy Devices.
• A detailed review of Neurovascular Thrombectomy Devices market; historical and forecasted market size is included in the report, covering devices outreach in the 7MM.
• The report provides an edge while developing business strategies, by understanding trends shaping and driving the Neurovascular Thrombectomy Devices market.

Key Topics Covered:

1 KEY INSIGHTS

2 REPORT INTRODUCTION

3 EXECUTIVE SUMMARY OF NEUROVASCULAR THROMBECTOMY DEVICES

4 NEUROVASCULAR THROMBECTOMY DEVICES: BACKGROUND AND OVERVIEW

4.1 INTRODUCTION

4.2 CAUSES AND SYMPTOMS

4.2.1 Causes of Neurovascular conditions

4.2.2 Symptoms

4.3 TREATMENT OPTIONS FOR STROKE

4.3.1 Antiplatelet Drug (Antiaggregant) Therapy

4.3.2 Thrombolytic Therapy

4.3.3 Neurothrombectomy devices

4.4 RISKS ASSOCIATED WITH THE NEUROVASCULAR THROMBECTOMY DEVICES

4.5 ADVANTAGES OF THE NEUROVASCULAR THROMBECTOMY DEVICES

4.6 DISADVANTAGES OF THE NEUROVASCULAR THROMBECTOMY DEVICES

5. NEUROVASCULAR THROMBECTOMY DEVICES: REGULATORY APPROVAL AND REIMBURSEMENT SCENARIO

5.1 NEUROVASCULAR THROMBECTOMY DEVICES: REGULATORY APPROVAL

5.1.1 United States Regulation of Neurovascular Thrombectomy Devices

5.1.2 European Regulation of Neurovascular Thrombectomy Devices

5.1.3 Japan Regulation of Neurovascular Thrombectomy Devices

5.2 NEUROVASCULAR THROMBECTOMY DEVICES: REIMBURSEMENT SCENARIO

5.2.1 Reimbursement Scenario in United States

5.2.2 Reimbursement Scenario in Europe

5.2.3 Reimbursement Scenario in Japan

6 NEUROVASCULAR THROMBECTOMY DEVICES: MARKETED PRODUCT PROFILING

6.1 KEY CROSS COMPETITION BASED ON DEVICE TYPE

6.2 COMPANY AND PRODUCT PROFILES

6.2.1 Edwards Lifesciences

6.2.2 Medtronic plc

6.2.3 Stryker Corporation

6.2.4 Penumbra Inc.

6.2.5 Terumo Corporation

6.2.6 MicroVention Inc

6.2.7 Acandis GmbH

6.2.8 Boston Scientific Corporation

6.2.9 Johnson & Johnson

6.2.10 Perflow Medical

6.2.11 phenox GmbH

7 NEUROVASCULAR THROMBECTOMY DEVICES: EMERGING DEVICES

7.1 ANACONDA BIOMEDS S.L.

7.1.1 Business Overview

7.1.2 Product Portfolio – ANCD Advanced Thrombectomy System

7.2 MIVI NEUROSCIENCE, INC.

7.2.1 Business Overview

7.2.2 Product Portfolio – Q Aspiration Catheter

7.2.3 Recent Developments

7.2.4 Clinical Trial

7.3 MICROVENTION INC

7.3.1 Product Portfolio- SOFIA Flow Plus 6F Aspiration Catheter with the Gomco 405 Aspiration Pump and Tubing Kit

7.3.2 Clinical Trial

8 ASSUMPTIONS AND RATIONALE

8.1 ELIGIBLE PATIENT POPULATION FOR NEUROVASCULAR THROMBECTOMY DEVICES

8.2 MARKET ANALYSIS FOR NEUROVASCULAR THROMBECTOMY DEVICES

9 NEUROVASCULAR THROMBECTOMY DEVICES: ELIGIBLE PATIENT POPULATION

9.1 7MM: ELIGIBLE PATIENT POPULATION FOR NEUROVASCULAR THROMBECTOMY DEVICES

9.2 THE UNITED STATES: ELIGIBLE PATIENT POPULATION FOR NEUROVASCULAR THROMBECTOMY DEVICES

9.3 GERMANY: ELIGIBLE PATIENT POPULATION FOR NEUROVASCULAR THROMBECTOMY DEVICES

9.4 FRANCE: ELIGIBLE PATIENT POPULATION FOR NEUROVASCULAR THROMBECTOMY DEVICES

9.5 ITALY: ELIGIBLE PATIENT POPULATION FOR NEUROVASCULAR THROMBECTOMY DEVICES

9.6 SPAIN: ELIGIBLE PATIENT POPULATION FOR NEUROVASCULAR THROMBECTOMY DEVICES

9.7 UNITED KINGDOM: ELIGIBLE PATIENT POPULATION FOR NEUROVASCULAR THROMBECTOMY DEVICES

9.8 JAPAN: ELIGIBLE PATIENT POPULATION FOR NEUROVASCULAR THROMBECTOMY DEVICES

10 NEUROVASCULAR THROMBECTOMY DEVICES: MARKET ANALYSIS

10.1 THE MARKET SIZE OF NEUROVASCULAR THROMBECTOMY DEVICES IN THE 7MM

10.2 UNITED STATES MARKET ANALYSIS (NEUROVASCULAR THROMBECTOMY DEVICES)

10.3 GERMANY MARKET ANALYSIS (NEUROVASCULAR THROMBECTOMY DEVICES)

10.4 FRANCE MARKET ANALYSIS (NEUROVASCULAR THROMBECTOMY DEVICES)

10.5 ITALY MARKET ANALYSIS (NEUROVASCULAR THROMBECTOMY DEVICES)

10.6 SPAIN MARKET ANALYSIS (NEUROVASCULAR THROMBECTOMY DEVICES)

10.7 UNITED KINGDOM MARKET ANALYSIS (NEUROVASCULAR THROMBECTOMY DEVICES)

10.8 JAPAN MARKET ANALYSIS (NEUROVASCULAR THROMBECTOMY DEVICES)

11 KOL’S VIEWS

12 MARKET DRIVERS

13 MARKET BARRIERS

14 UNMET NEEDS

15 PEST ANALYSIS

16 APPENDIX

16.1 Bibliography

16.2 Report Methodology

17 Publisher Capabilities

18 DISCLAIMER

19 About the Publisher

For more information about this report visit https://www.researchandmarkets.com/r/prfg2p

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900